GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,756,000 | -33.9% | 60,000 | +79.6% | 0.63% | +24.3% |
| Q4 2019 | $2,655,000 | -83.2% | 33,400 | -88.9% | 0.51% | -84.5% |
| Q2 2019 | $15,780,000 | -0.6% | 300,000 | 0.0% | 3.27% | -21.1% |
| Q1 2019 | $15,879,000 | +109.1% | 300,000 | +62.2% | 4.15% | +50.5% |
| Q4 2018 | $7,594,000 | +23.4% | 185,000 | +14.2% | 2.76% | +110.5% |
| Q3 2018 | $6,156,000 | -43.7% | 162,000 | -33.1% | 1.31% | -59.3% |
| Q2 2018 | $10,938,000 | -14.5% | 242,000 | -25.5% | 3.22% | +7.3% |
| Q4 2017 | $12,789,000 | +64.7% | 325,000 | +30.0% | 3.00% | +81.9% |
| Q3 2017 | $7,763,000 | – | 250,000 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |